Cargando…
Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone
PURPOSE/OBJECTIVES: To assess adverse events (AEs) and disease-specific outcomes after proton therapy for isolated local-regional recurrence (LRR) of breast cancer after mastectomy without prior radiotherapy (RT). MATERIALS/METHODS: Patients were identified from a multi-institutional prospective reg...
Autores principales: | Laughlin, Brady S., Bhangoo, Ronik S., Niska, Joshua R., Thorpe, Cameron S., Girardo, Marlene E., Anderson, Justin D., Kosiorek, Heidi E., McGee, Lisa A., Hartsell, William F., Chang, John H., Rossi, Carl J., Tsai, Henry K., Choi, Isabelle J., Vargas, Carlos E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742552/ https://www.ncbi.nlm.nih.gov/pubmed/36518323 http://dx.doi.org/10.3389/fonc.2022.925078 |
Ejemplares similares
-
Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: A single-center registry experience
por: Laughlin, Brady S., et al.
Publicado: (2022) -
Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapy
por: Bulman, Gabriella F., et al.
Publicado: (2021) -
Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer
por: Bhangoo, Ronik S., et al.
Publicado: (2021) -
Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery
por: Thorpe, Cameron S., et al.
Publicado: (2022) -
Radiation Recall Dermatitis After the Use of Pralatrexate for Peripheral T-cell Lymphoma
por: Bhangoo, Ronik S., et al.
Publicado: (2018)